Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review

• Simon J Griffin,
• Hajira Dambha-Miller,
• Ali Albasri,
• Christopher R Wilcox,
• Sam Hodgson,
• Shareen Khan

Affiliations

Simon J Griffin

1 MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, Cambridgeshire, UK

Hajira Dambha-Miller

Primary Care Research Centre, University of Southampton, Southampton, UK

Ali Albasri

research fellow

Christopher R Wilcox

Primary Care Research Centre, University of Southampton, Southampton, UK

Sam Hodgson

Department of Primary Care, University of Southampton, Southampton, UK

Shareen Khan

Oxford University Hospitals NHS Trust, Oxford, UK